Comparison of effectiveness and safety of lasmiditan and CGRP-antagonists for the acute treatment of migraine in adults: systematic review and network meta-analysis of randomised trials

Comparison of effectiveness and safety of lasmiditan and CGRP-antagonists for the acute treatment of migraine in adults: systematic review and network meta-analysis of randomised trials

Abstract Objective To compare the outcomes associated with the use of lasmiditan, rimegepant, ubrogepant, and zavegepant for the acute management of migraine headaches. Methods We searched four electronic databases from database inception to August 31, 2023, to identify randomized controlled trials...

Descripción completa

Detalles Bibliográficos
Autores principales: Xinxin Deng, Liying Zhou, Cui Liang, Xue Shang, Xu Hui, Wendi Liu, Shanshan Liang, Yongsheng Wang, Meng Xu, Kangle Guo, Kehu Yang, Xiuxia Li
Formato: Artículo
Lenguaje:English
Publicado: BMC 2024-02-01
Colección:The Journal of Headache and Pain
Materias:
Acute treatments
Migraine
Lasmiditan
CGRP
Network meta-analyses
Efficacy
Acceso en línea:https://doi.org/10.1186/s10194-024-01723-4

Internet

https://doi.org/10.1186/s10194-024-01723-4

Ejemplares similares